Newborn screening programmes: Emerging biobanks?

Norsk Epidemiologi

Volumn 21, Issue 2, 2012, Pages 163-168

  Knoppers, Bartha Maria ^a   Avard, D ^a   Senecal K ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AWARENESS; BLOOD SAMPLING; HEALTH CARE POLICY; HEALTH PROGRAM; INFORMED CONSENT; MEDICAL RESEARCH; MEDICOLEGAL ASPECT; NEWBORN CARE; NEWBORN SCREENING; PATIENT RIGHT; PUBLIC HEALTH; QUALITY CONTROL;

EID: 84863008156     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v21i2.1489     Document Type: Article

References (66)

1. Lewis MH, Goldenberg A, Anderson R, Rothwell E, Botkin J. State laws regarding the retention and use of residual newborn screening blood samples. Pediatrics 2011; 127: 703-12.
2. Andrews LB, Fullarton JE, Holtzman NA, Motulski AG (eds). Assessing genetic risks: implications for health and social policy. Washington, DC: National Academy Press, 1994.
3. Wilson JM, Jungner YG. Principles and practice of mass screening for disease, 1968. http://whqlibdoc. who.int/php/WHO_PHP_34.pdf. Accessed 6 January 2012.
4. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull WHO 2008; 86 (4): 317-9.
5. Ross LF. Mandatory versus voluntary consent for newborn screening? Kennedy Inst Ethics J 2010; 20 (4): 299-328.
6. Watson MS, Mann MY, Lloyd-Puryear MA, Rinaldo P, Howell RR. Newborn screening: Toward a uniform screening panel and system-executive summary. Pediatrics 2006; 117 (5): S296.
7. Tarini BA. Storage and use of residual newborn screening blood spots: A public policy emergency. Genet Med 2011; 13 (7): 619.
8. Public Population Project in Genomics (P3G). Population Biobanks Lexicon, 2007. http://www. p3gobservatory.org/download/Biobanks_Lexicon.pdf. Accessed 29 June 2011.
9. Unsgaard E, Meloy JR. The assassination of the Swedish minister for foreign affairs. J Forensic Sci 2011; 56: 555-9.
10. Hartman D, Benton L, Morenos L, Beyer J, Spiden M, Stock A. The importance of Guthrie cards and other medical samples for the direct matching of disaster victims using DNA profiling. Forensic Sci Int 2011; 205 (1-3): 59-63.
11. Hartman D, Drummer O, Eckhoff C, Scheffer J, Stringer P. The contribution of DNA to the disaster victim identification (DVI) effort. Forensic Sci Int 2011; 205 (1-3): 52-8.
12. Kharaboyan L, Avard D, Knoppers BM. Storing newborn blood spots: modern controversies. J Law Med Ethics 2004; 32: 741.
13. Olson S, Berger AC. Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary. Washington, DC: National Academy Press, 2010.
14. Belono V et al. Texas Department of State Health Services, 2009.
15. Bearder V et al. Minnesota et al., 2009.
16. LD (Guardian ad litem of) v. Provincial Health Services Authority, British Columbia, 2011.
17. Oklahoma State Senate. Unauthorized Storage and Use of DNA from Newborn Without Parental Consent. S 1250. 52nd Legislature. 2nd Regular Session, 2010.
18. Idaho State. IDAPA 16.02.12. http://adm.idaho.gov/adminrules/rules/idapa16/0212.pdf.
19. Secretary's Advisory commitee on Heritable Disorders in Newborns and Children. Briefing Paper-Considerations and Recommendations for National Guidance Regarding the Retention and Use of Residual Dried Blood Spot Specimens after Newborn Screening, 2010. http://www.hrsa.gov/heritabledisorderscommittee/ reports/RBSBriefingPaper0923.pdf. Accessed 29 June 2011.
20. Provincial Health Services Authority (British Columbia-Canada). Storage, Use, Retention and Disposal of Newborn Screening Blood Spot Cards: Policy and Procedure, 2010.
21. Swedish Ministry of Health and Social Affairs. Report: A New Biobank Act (SOU 2010: 81), 2010. http:/ /www.regeringen.se/content/1/c6/15/65/67/d5441333.pdf. Accessed 29 June 2011.
22. German Federal Parliament. Human Genetic Examination Act (Genetic Diagnosis Act-GenDG, 2009. http://www.eurogentest.org/uploads/1247230263295/GenDG_German_English.pdf. Accessed 5 July 2011.
23. Flemish Agency for Care and Health. Vlaams bevolkingsonderzoek naar aangeboren aandoeningen bij pasgeborenen op een bloedstaal, 2010.
24. National Cancer Institute. http://www.cancer.gov/. Accessed 5 July 2011.
25. American Association of Tissue Banks. http://www.aatb.org. Accessed 30 June 2011.
26. Framingham Heart Study. http://www.framinghamheartstudy.org/. Accessed 30 June 2011.
27. The Health Council of the Netherlands. Neonatal Screening, 2005. http://www.gezondheidsraad.nl/sites/ default/files/05@11E.pdf. Accessed 29 June 2011.
28. Nørgaard-Pedersen B, Hougaard DM. Storage policies and use of the Danish Newborn Screening Biobank. J Inherit Metab Dis 2007; 30 (4): 530-6.
29. New Zealand Genetic Services-National Testing Centre. Return of newborn metabolic screening samples (Gutherie cards) to family, 2009. http://www.adhb.govt.nz/newborn/Guidelines/Nutrition/ GuthrieCardReturn.pdf. Accessed 29 June 2011.
30. UK Newborn Screening Programme Centre. Newborn Blood Spot Screening in the UK, Policies and Standards, 2005.
31. Human Genetics Society of Australia. Retention, Storage, and Use of Sample Cards from Newborn Screening Programs, 2004. https://www.hgsa.org.au/website/wp-content/uploads/2009/12/2000-P03.pdf. Accessed 29 June 2011.
32. Government of New South Wales-Department of Health. Newborn Bloodspots Screening Policy, 2006. http://www.health.nsw.gov.au/policies/pd/2006/pdf/PD2006_099.pdf. Accessed 29 June 2011.
33. Rothwell EW, Anderson RA, Burbank MJ, et al. Concerns of newborn blood screening advisory committee members regarding storage and use of residual newborn screening blood spots. Am J Public Health 2011; 101: 2111-6.
34. Comité d'éthique-Association française pour le dépistage et la prévention des handicaps de l'enfants. Les prélèvements de sang sur papier pour le dépistage néonatal: recommandations pour leur collecte, leur traitement et leur conservation. Archives de Pédiatrie 1995; 2 (1): 3-7. at.5.
35. Institut national de santé publique du Québec. Rapport d'évaluation du programme québécois de dépistage sanguin des maladies génétiques chez le nouveau-né, 2005. at. 14. http://www.inspq.qc.ca/pdf/publications/ 484-RapportDepistageSanguin.pdf. Accessed 29 June 2011.
36. Irish Council for Bioethics. Human Biological Material: Recommendations for Collection, Use and Storage in Research, 2005. at. 80. http://www.bioethics.ie/uploads/docs/BiologicalMaterial.pdf. Accessed 29 June 2011.
37. Swiss Academy of Medical Sciences (SAMS). Biobanks: Obtainment, preservation and utilisation of human biological material, 2006.
38. Belgian Act (2008). Wet inzake het verkrijgen en het gebruik van menselijk lichaamsmateriaal met hetoog op de geneeskundige toepassing op de mens of het wetenschappelijk onderzoek. As passed by the Parliament of Belgium and given Royal Assent in December 2008.
39. Dutch Civil Code. Burgerlijk Wetboek. s. 7: 467.
40. American College of Medical Genetics. Position Statement on Importance of Residual Newborn Screening Dried Blood Spots, 2009. http://www.acmg.net/StaticContent/NewsReleases/Blood_Spot_Position_ Statement2009.pdf. Accessed 29 June 2011.
41. Australian Government Agency Biotechnology Australia. Genetics in Family Medicine: The Australian Handbook for General Practitioners-Newborn Screening, 2007. http://www.nhmrc.gov.au/_files_nhmrc/file/your_ health/egenetics/GeneticsInFamilyMedicine_WEB.pdf. Accessed 29 June 2011.
42. German National Ethics Council. Opinion Biobanks for Research. http://www.ethikrat.org/_english/ publications/Opinion_Biobanks-for-research.pdf. 2004.
43. UK Newborn Screening Programme Centre (NHS). Code of Practice for the Retention and Storage of Residual Spots, 2005. http://newbornbloodspot.screening.nhs.uk/cms.php?folder=2547. Accessed 29 June 2011.
44. Chrysler D, McGee H, Bach J, Goldman E, Jacobson PD. The Michigan BioTrust for Health: Using dried bloodspots for research to benefit the community while respecting the individual. J Law Med Ethics 2011; 39: 98-101.
45. Cal. Health and Safety Code §125000 through 125002 (2008). (www.leginfo.ca.gov/cgi-bin/displaycode? section_hsc& group_124001-125000&file_125000-125002).
46. Public Population Project in Genomics (P3G). Population Biobanks Lexicon, 2007. http://www. p3gobservatory.org/download/Biobanks_Lexicon.pdf. Accessed June 29 2011.
47. Organization for Economic Co-operation and Development. OECD Guidelines on Human Biobanks and Genetic Research Databases, 2009. http://www.oecd.org/dataoecd/41/47/44054609.pdf. Accessed June 29 2011.
48. Knoppers BM. Biobanking: international norms. J Law Med Ethics 2005; 33 (1): 7-14.
49. Tubafrost Central Database-the European Human Tumor Frozen Tissue Bank. http://tubafrost.org/. Accessed 5 July 2011.
50. Riegman PH, van Veen EB. Biobanking residual tissues. Hum Genet 2011; 130: 357-68.
51. National Cancer Institute-Office of Biorepositories and Biospecimen Research. http://biospecimens.cancer. gov/default.asp. Accessed 5 July 2011.
52. Murray TH. Genetic exceptionalism and "future diaries": is genetic information different from other medical information? In: Rothstein M (ed.), Genetic secrets: Protecting privacy and confidentiality in the genetic era. New Haven: Yale University Press 1997: 60-73.
53. Estonia Government. Human Genes Research Act, 2000. http://www.legaltext.ee/text/en/X50010.htm. Accessed 5 July 2011.
54. Stolk RP, et al. Universal risk factors for multifactorial diseases: LifeLines: a three-generation populationbased study. Eur J Epidemiol 2008; 23: 67-74.
55. The BioBank Japan Project on the implication of personalized medicine. http://www.src.riken.jp/english/ project/person/index.html. Accessed 5 July 2011.
56. U.S. Department of Health & Human Services-Office for Human Research Protection (OHRP). Guidance on Research Involving Coded Private Information of Biological Specimens, 2008. http://www.hhs.gov/ohrp/ policy/cdebiol.pdf. Accessed 5 July 2011.
57. Brothers KB, Clayton EW. " Human non-subjects research": privacy and compliance. AJOB 2010; 10 (9): 15.
58. Poste G. Bring on the biomarkers. Nature 2011; 469 (7329): 156-7.
59. Kapp MB. Ethical and legal issues in research involving human subjects: do you want a piece of me? J Clin Pathol 2006; 59 (4): 335.
60. Olney RS, Moore CA, Ojodu JA, Lindegren ML, Hannon WH. Storage and use of residual dried blood spots from state newborn screening programs. J Pediatr 2006; 148 (5): 618-22.
61. Muchamore I, Morphett L, Barlow-Stewart K. Exploring existing and deliberated community perspectives of newborn screening: informing the development of state and national policy standards in newborn screening and the use of dried blood spots. Aust New Zealand Health Policy 2006; 3 (1): 14.
62. Duquette D, Rafferty A, Fussman C, Gehring J, Meyer S, Bach J. Public support for the use of newborn screening dried blood spots in health research. Public Health Genomics 2011; 14: 143-52.
63. Fant KE, Clark SJ, Kemper AR. Completeness and complexity of information available to parents from newborn-screening programs. Pediatrics 2005; 115 (5): 1268.
64. Avard D, Vallance H, Greenberg C, Laberge C, Kharaboyan L, Plant M. Variability in the storage and use of newborn dried bloodspots in Canada: is it time for national standards? Genomics Soc Policy 2006; 2 (3): 80-95.
65. Sweden Government. Ministry of Health and Social Affairs. Biobanks in Medical Care Act (2002: 297), May 23, 2003. http://www.sweden.gov.se/content/1/c6/02/31/26/f69e36fd.pdf. Accessed 5 July 2011.
66. th Anniversary Nuffield Lecture (unpublished). Delivered at the Royal Society of Arts, 19 May 2011.